☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
Genmab
PharmaShots' Key Highlights of Second Quarter 2024
July 2, 2024
Genmab to Acquire ProfoundBio for Enhancing its Oncology Portfolio
April 3, 2024
Genmab Receives MHLW Approval for Epkinly (epcoritamab) for Adults Patients with Large B-Cell Lymphoma
September 25, 2023
Genmab and Seagen Report P-III Trial (innovaTV 301) Results of Tivdak (tisotumab vedotin-tftv) for Recurrent or Metastatic Cervica...
September 5, 2023
Tahi Ahmadi and Asud Khaliq Share their Views on EPKINLY (epcoritamab) U.S. FDA Approval in DLBCL
August 2, 2023
Genmab and AbbVie Report P-I/II Trial (EPCORE NHL-1) Results of Epcoritamab for the Treatment of Relapsed/Refractory Follicular Ly...
June 28, 2023
Load more...
Back to Home